| Molecular Biology of Cancer Contributor(s): MacDonald, F. (Author), Ford, C. H. J. (Author), Casson, A. G. (Author) |
|
 |
ISBN: 1859962475 ISBN-13: 9781859962473 Publisher: Taylor & Francis OUR PRICE: $114.00 Product Type: Paperback - Other Formats Published: March 2004 Annotation: The Advanced Text series is designed for students taking advanced-level courses, including upper-level undergraduates and graduate students. Titles in this series will also be invaluable to researchers new to a field, and to established researchers as a basic reference text. "Molecular Biology of Cancer," Second Edition, is now in a larger format and has been extensively revised. It covers heredity cancer, microarray technology and increased study of childhood cancers. It continues to provide a detailed overview of the processes, which lead to the development and proliferation of cancer cells, as well as the techniques available for their study. The book also describes the means by which tumor suppressor genes and oncogenes may be used in the diagnosis and in determining the prognosis of a wide variety of cancers, including breast, genitourinary, lung and gastrointestinal cancer. |
| Additional Information |
| BISAC Categories: - Science | Life Sciences - Molecular Biology - Science | Life Sciences - Biology - Science | Life Sciences - Cell Biology |
| Dewey: 616.994 |
| LCCN: 2004001336 |
| Series: Advanced Texts |
| Physical Information: 0.54" H x 6.84" W x 9.74" (1.24 lbs) 269 pages |
| Descriptions, Reviews, Etc. |
| Publisher Description: Molecular Biology of Cancer has been extensively revised and covers heredity cancer, microarray technology and increased study of childhood cancers. It continues to provide a detailed overview of the process which lead to the development and proliferation of cancer cells, including the techniques available for their study. It also describes the means by which tumor suppressor genes and oncogenes may be used in the diagnosis and in determining the prognosis of a wide variety of cancers, including breast, genitourinary, lung and gastrointestinal cancer. |